Propoxyphene Napsylate And Acetaminophen
Product Images NDC 12634-537

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Propoxyphene Napsylate And Acetaminophen (NDC 12634-537). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotheca, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Structural Formula (Prop 01)

Image Of Structural Formula (Prop 01)
Chemical structure of propoxyphene napsylate monohydrate, an active ingredient in PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN by Apotheca, Inc.*
FDA Label Image

Image Of Formula (Prop 02)

Image Of Formula (Prop 02)
Chemical structure of acetaminophen showing a benzene ring with hydroxyl (OH) and acetamido (NHCOCH3) functional groups attached.*
FDA Label Image

Image Of Label (Prop 03)

Image Of Label (Prop 03)
Label for Propoxyphene Napsylate and Acetaminophen tablets, 100mg/650mg, noted as a Schedule CIV drug for prescription use only. The label includes patient and doctor information fields, dosage directions, warnings about drowsiness, alcohol effects, and legal restrictions. It lists Teva as the manufacturer and Apotheca Inc. in Phoenix, AZ 85006 as the repackager.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.